価格表

在庫・価格 : 2024年06月08日 09時27分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-VEGF-C, Human, Goat-Poly
データシート※最新のデータシートでない場合があります
AF752 RSDアールアンドディー システムス
R&D Systems, Inc.
100 μg ¥105,000
(未発注)
追加

在庫・価格 : 2024年06月08日 09時27分 現在

Anti-VEGF-C, Human, Goat-Poly

  • 商品コード:AF752
  • メーカー:RSD
  • 包装:100μg
  • 価格: ¥105,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Wauke K et al. Expression and localization of vascular endothelial growth factor-C in rheumatoid arthritis synovial tissue. J. Rheumatol. 2002 Jan;29(1):34-8
Wauke K et al
2002/01/01
Application: Western Blot, Sample Type: Homogenized Tissue PubMed
2 Kubo H et al. Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea. Proc. Natl. Acad. Sci. U.S.A. 2002 Jun;99(13):8868-73
Kubo H et al
2002/01/01
mouse eye PubMed
3 Saaristo A et al. Lymphangiogenic gene therapy with minimal blood vascular side effects. J. Exp. Med. 2002 Sep;196(6):719-30
Saaristo A et al
2002/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
4 Tsai PW et al. Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway. J. Biol. Chem. 2003 Feb;278(8):5750-9
Tsai PW et al
2003/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
5 Nakamura Y et al. Clinicopathological significance of vascular endothelial growth factor-C in breast carcinoma with long-term follow-up. Mod. Pathol. 2003 Apr;16(4):309-14
Nakamura Y et al
2003/01/01
Application: IHC Paraffin-embedded, Sample Type: Whole Tissue PubMed
6 Su JL et al. Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma. Cancer Res. 2004 Jan;64(2):554-64
Su JL et al
2004/01/01
Application: IHC Paraffin-embedded,Western Blot, Sample Type: Cell Lysates,Whole Tissue PubMed
7 Zeng Y et al. Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer. Clin. Cancer Res. 2004 Aug;10(15):5137-44
Zeng Y et al
2004/01/01
Application: IHC Paraffin-embedded, Sample Type: Whole Tissue PubMed
8 Sipos B et al. Expression of lymphangiogenic factors and evidence of intratumoral lymphangiogenesis in pancreatic endocrine tumors. Am. J. Pathol. 2004 Oct;165(4):1187-97
Sipos B et al
2004/01/01
Application: IHC Paraffin-embedded, Sample Type: Whole Tissue PubMed
9 Rubbia-Brandt L et al. Lymphatic vessel density and vascular endothelial growth factor-C expression correlate with malignant behavior in human pancreatic endocrine tumors. Clin. Cancer Res. 2004 Oct;10(20):6919-28
Rubbia-Brandt L et al
2004/01/01
Application: IHC Paraffin-embedded, Sample Type: Whole Tissue PubMed
10 Li J et al. Upregulation of VEGF-C by androgen depletion: the involvement of IGF-IR-FOXO pathway. Oncogene 2005 Aug;24(35):5510-20
Li J et al
2005/01/01
Species: Human, Application: Western Blot, Sample type: Whole Cells PubMed
11 Le Bras B et al. VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain. Nat. Neurosci. 2006 Mar;9(3):340-8
Le Bras B et al
2006/01/01
Species: Mouse, Application: IHC Frozen, Whole Tissue PubMed
12 Nakamura Y et al. Nitric oxide in breast cancer: induction of vascular endothelial growth factor-C and correlation with metastasis and poor prognosis. Clin. Cancer Res. 2006 Feb;12(4):1201-7
Nakamura Y et al
2006/01/01
Application: IHC Paraffin-embedded, Sample Type: Whole Tissue PubMed
13 Zeng Y et al. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis. Cancer Res. 2006 Oct;66(19):9566-75
Zeng Y et al
2006/01/01
Species: Human, Application: Neutralization, Sample type: Whole Cells PubMed
14 Keskitalo S et al. Enhanced capillary formation stimulated by a chimeric vascular endothelial growth factor/vascular endothelial growth factor-C silk domain fusion protein. Circ. Res. 2007 May;100(10):1460-7
Keskitalo S et al
2007/01/01
Species: Human, Application: Immunoprecipitation, Sample type: Whole Cells PubMed
15 Kilic N et al. Lymphatic reprogramming of microvascular endothelial cells by CEA-related cell adhesion molecule-1 via interaction with VEGFR-3 and Prox1. Blood 2007 Dec;110(13):4223-33
Kilic N et al
2007/01/01
Species: Human, Application: Western Blot, Sample type: Cell Lysates PubMed
16 Kodama M et al. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms. Clin. Cancer Res. 2008 Nov;14(22):7205-14
Kodama M et al
2008/01/01
Application: IHC Paraffin-embedded, Sample Type: Whole Tissue PubMed
17 Matsuura M et al. Autocrine loop between vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 positively regulates tumor-associated lymphangiogenesis in oral squamoid cancer cells. Am. J. Pathol. 2009 Oct;175(4):1709-21
Matsuura M et al
2009/01/01
Application: IHC Fresh, Sample Type: Whole Cells PubMed
18 Donoghue JF et al. Dilated thin-walled blood and lymphatic vessels in human endometrium: a potential role for VEGF-D in progestin-induced break-through bleeding. PLoS ONE 2012;7(2):e30916
Donoghue JF et al
2012/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
19 Lin CE et al. Lysophosphatidic acid enhances vascular endothelial growth factor-C expression in human prostate cancer PC-3 cells. PLoS ONE 2012;7(7):e41096
Lin CE et al
2012/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
20 Lewin J et al. A phase Ib/II translational study of sunitinib with neoadjuvant radiotherapy in soft-tissue sarcoma. Br. J. Cancer 2014 Dec;111(12):2254-61
Lewin J et al
2014/01/01
Application: IHC, Sample Type: tissue PubMed
21 Jha SK et al. Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1. Sci Rep 2017 Jul;7(1):4916
Jha SK et al
2017/01/01
Species: Primate - Chlorocebus aethiops (African Green Monkey), Applications: WB PubMed
22 Kitano H et al. Synaptonemal complex protein 3 is associated with lymphangiogenesis in non-small cell lung cancer patients with lymph node metastasis. J Transl Med 2017 Jun;15(1):138
Kitano H et al
2017/01/01
Species: Human, Applications: WB PubMed
23 Åström P et al. The interplay of matrix metalloproteinase-8, transforming growth factor-β1 and vascular endothelial growth factor-C cooperatively contributes to the aggressiveness of oral tongue squamous cell carcinoma. Br. J. Cancer 2017 Sep;117(7)
Åström P et al
2017/01/01
PubMed
24 Rudziナгka M et al. Transcription Factor Prospero Homeobox 1 (PROX1) as a Potential Angiogenic Regulator of Follicular Thyroid Cancer Dissemination. Int J Mol Sci 2019 Nov;20(22)
Rudziナгka M et al
2019/01/01
PubMed
25 Song E et al. VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumours. Nature 2020 01;577(7792):689-694
Song E et al
2020/01/01
PubMed
26 Szナ遡e D et al. Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema. Nat Commun 2021 06;12(1):3460
Szナ遡e D et al
2021/01/01
PubMed
27 Hwang I et al. Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients. J Transl Med 2020 11;18(1):443
Hwang I et al
2020/01/01
Species: Human, Applications: IHC PubMed
  • No.: 1
  • 文献情報:
    Wauke K et al. Expression and localization of vascular endothelial growth factor-C in rheumatoid arthritis synovial tissue. J. Rheumatol. 2002 Jan;29(1):34-8
    Wauke K et al
    2002/01/01
  • 備考:
    Application: Western Blot, Sample Type: Homogenized Tissue
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Kubo H et al. Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea. Proc. Natl. Acad. Sci. U.S.A. 2002 Jun;99(13):8868-73
    Kubo H et al
    2002/01/01
  • 備考:
    mouse eye
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Saaristo A et al. Lymphangiogenic gene therapy with minimal blood vascular side effects. J. Exp. Med. 2002 Sep;196(6):719-30
    Saaristo A et al
    2002/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Tsai PW et al. Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway. J. Biol. Chem. 2003 Feb;278(8):5750-9
    Tsai PW et al
    2003/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Nakamura Y et al. Clinicopathological significance of vascular endothelial growth factor-C in breast carcinoma with long-term follow-up. Mod. Pathol. 2003 Apr;16(4):309-14
    Nakamura Y et al
    2003/01/01
  • 備考:
    Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Su JL et al. Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma. Cancer Res. 2004 Jan;64(2):554-64
    Su JL et al
    2004/01/01
  • 備考:
    Application: IHC Paraffin-embedded,Western Blot, Sample Type: Cell Lysates,Whole Tissue
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Zeng Y et al. Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer. Clin. Cancer Res. 2004 Aug;10(15):5137-44
    Zeng Y et al
    2004/01/01
  • 備考:
    Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Sipos B et al. Expression of lymphangiogenic factors and evidence of intratumoral lymphangiogenesis in pancreatic endocrine tumors. Am. J. Pathol. 2004 Oct;165(4):1187-97
    Sipos B et al
    2004/01/01
  • 備考:
    Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Rubbia-Brandt L et al. Lymphatic vessel density and vascular endothelial growth factor-C expression correlate with malignant behavior in human pancreatic endocrine tumors. Clin. Cancer Res. 2004 Oct;10(20):6919-28
    Rubbia-Brandt L et al
    2004/01/01
  • 備考:
    Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Li J et al. Upregulation of VEGF-C by androgen depletion: the involvement of IGF-IR-FOXO pathway. Oncogene 2005 Aug;24(35):5510-20
    Li J et al
    2005/01/01
  • 備考:
    Species: Human, Application: Western Blot, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Le Bras B et al. VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain. Nat. Neurosci. 2006 Mar;9(3):340-8
    Le Bras B et al
    2006/01/01
  • 備考:
    Species: Mouse, Application: IHC Frozen, Whole Tissue
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Nakamura Y et al. Nitric oxide in breast cancer: induction of vascular endothelial growth factor-C and correlation with metastasis and poor prognosis. Clin. Cancer Res. 2006 Feb;12(4):1201-7
    Nakamura Y et al
    2006/01/01
  • 備考:
    Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Zeng Y et al. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis. Cancer Res. 2006 Oct;66(19):9566-75
    Zeng Y et al
    2006/01/01
  • 備考:
    Species: Human, Application: Neutralization, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Keskitalo S et al. Enhanced capillary formation stimulated by a chimeric vascular endothelial growth factor/vascular endothelial growth factor-C silk domain fusion protein. Circ. Res. 2007 May;100(10):1460-7
    Keskitalo S et al
    2007/01/01
  • 備考:
    Species: Human, Application: Immunoprecipitation, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Kilic N et al. Lymphatic reprogramming of microvascular endothelial cells by CEA-related cell adhesion molecule-1 via interaction with VEGFR-3 and Prox1. Blood 2007 Dec;110(13):4223-33
    Kilic N et al
    2007/01/01
  • 備考:
    Species: Human, Application: Western Blot, Sample type: Cell Lysates
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Kodama M et al. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms. Clin. Cancer Res. 2008 Nov;14(22):7205-14
    Kodama M et al
    2008/01/01
  • 備考:
    Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Matsuura M et al. Autocrine loop between vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 positively regulates tumor-associated lymphangiogenesis in oral squamoid cancer cells. Am. J. Pathol. 2009 Oct;175(4):1709-21
    Matsuura M et al
    2009/01/01
  • 備考:
    Application: IHC Fresh, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Donoghue JF et al. Dilated thin-walled blood and lymphatic vessels in human endometrium: a potential role for VEGF-D in progestin-induced break-through bleeding. PLoS ONE 2012;7(2):e30916
    Donoghue JF et al
    2012/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Lin CE et al. Lysophosphatidic acid enhances vascular endothelial growth factor-C expression in human prostate cancer PC-3 cells. PLoS ONE 2012;7(7):e41096
    Lin CE et al
    2012/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Lewin J et al. A phase Ib/II translational study of sunitinib with neoadjuvant radiotherapy in soft-tissue sarcoma. Br. J. Cancer 2014 Dec;111(12):2254-61
    Lewin J et al
    2014/01/01
  • 備考:
    Application: IHC, Sample Type: tissue
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Jha SK et al. Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1. Sci Rep 2017 Jul;7(1):4916
    Jha SK et al
    2017/01/01
  • 備考:
    Species: Primate - Chlorocebus aethiops (African Green Monkey), Applications: WB
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Kitano H et al. Synaptonemal complex protein 3 is associated with lymphangiogenesis in non-small cell lung cancer patients with lymph node metastasis. J Transl Med 2017 Jun;15(1):138
    Kitano H et al
    2017/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Åström P et al. The interplay of matrix metalloproteinase-8, transforming growth factor-β1 and vascular endothelial growth factor-C cooperatively contributes to the aggressiveness of oral tongue squamous cell carcinoma. Br. J. Cancer 2017 Sep;117(7)
    Åström P et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Rudziナгka M et al. Transcription Factor Prospero Homeobox 1 (PROX1) as a Potential Angiogenic Regulator of Follicular Thyroid Cancer Dissemination. Int J Mol Sci 2019 Nov;20(22)
    Rudziナгka M et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Song E et al. VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumours. Nature 2020 01;577(7792):689-694
    Song E et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Szナ遡e D et al. Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema. Nat Commun 2021 06;12(1):3460
    Szナ遡e D et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Hwang I et al. Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients. J Transl Med 2020 11;18(1):443
    Hwang I et al
    2020/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed